Tesevatinib is a quinazoline-based compound that functions as a multi-target tyrosine kinase inhibitor, targeting receptors such as EGFR, ErbB2, KDR, Flt4, and EphB4. It is investigated for its anticancer properties and is used as a pharmaceutical raw material or research compound.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 781613-23-8
Diclofenac diethylamine
pharmaceutical raw material
Paroxetine hydrochloride
pharmaceutical raw material
Rosiptor
pharmaceutical raw material
Nepafenac
pharmaceutical raw material
7-[[(3aS,6aR)-2-methyl-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-5-yl]methoxy]-N-(3,4-dichloro-2-fluorophenyl)-6-methoxyquinazolin-4-amine
HVXKQKFEHMGHSL-GOOCMWNKSA-N
CN1C[C@H]2CC(C[C@H]2C1)COC3=C(C=C4C(=C3)N=CN=C4NC5=C(C(=C(C=C5)Cl)Cl)F)OC